Viewing Study NCT01536392


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-01-01 @ 9:01 PM
Study NCT ID: NCT01536392
Status: COMPLETED
Last Update Posted: 2021-06-11
First Post: 2012-02-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of the Cervix View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer of the Cervix View
None Anti-emetic therapy View
None Granisetron View
None Transdermal patch View
None Ondansetron View
None Zofran View
None Questionnaires View
None Surveys View
None Study Drug Diary View
None Nausea and Vomiting View